Table 2. Clinical features of 29 patients with FN (n=29).
| Characteristics | No. (%) |
|---|---|
| ECOG PS | |
| 1 | 28 (96.6) |
| 2 | 1 (3.4) |
| Type of infection | |
| Microbiologically documented | 0 (0.0) |
| Clinically documented | 5 (17.2) |
| Fever of unknown origin | 24 (82.8) |
| Prophylactic antibiotics | 0 (0.0) |
| Prophylactic G-CSF | 13 (44.8) |
| Magnesium oxide | 18 (62.1) |
| Previous LVFX within 3 months | 3 (10.3) |
| Previous hospitalization within 3 months | 18 (62.1) |
| Blood parameters (median) | |
| White blood cells | 0.80×109/L |
| Neutrophils | 0.26×109/L |
| Hemoglobin | 10.6 g/dL |
| Platelets | 130×109/L |
| Albumin | 3.6 g/dL |
| Creatinine | 0.8 mg/dL |
| Total bilirubin | 0.7 mg/dL |
| Aspartate aminotransferase | 21 U/L |
| Alanine aminotransferase | 25 U/L |
| Lactate dehydrogenase | 178 U/L |
| Glucose | 112 mg/dL |
| C-reactive protein | 0.8 mg/dL |
ECOG PS: Eastern Cooperative Oncology Group Performance Status, G-CSF: granulocyte-colony stimulating factor, LVFX: levofloxacin